227 related articles for article (PubMed ID: 26086877)
1. Tumour-suppressive function of SIRT4 in human colorectal cancer.
Miyo M; Yamamoto H; Konno M; Colvin H; Nishida N; Koseki J; Kawamoto K; Ogawa H; Hamabe A; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Doki Y; Mori M; Ishii H
Br J Cancer; 2015 Jul; 113(3):492-9. PubMed ID: 26086877
[TBL] [Abstract][Full Text] [Related]
2. Clinical and therapeutic significance of sirtuin-4 expression in colorectal cancer.
Huang G; Cheng J; Yu F; Liu X; Yuan C; Liu C; Chen X; Peng Z
Oncol Rep; 2016 May; 35(5):2801-10. PubMed ID: 26986234
[TBL] [Abstract][Full Text] [Related]
3. SIRT4 functions as a tumor suppressor during prostate cancer by inducing apoptosis and inhibiting glutamine metabolism.
Cai G; Ge Z; Xu Y; Cai L; Sun P; Huang G
Sci Rep; 2022 Jul; 12(1):12208. PubMed ID: 35842463
[TBL] [Abstract][Full Text] [Related]
4. SIRT4 is the molecular switch mediating cellular proliferation in colorectal cancer through GLS mediated activation of AKT/GSK3β/CyclinD1 pathway.
Cui Y; Bai Y; Yang J; Yao Y; Zhang C; Liu C; Shi J; Li Q; Zhang J; Lu X; Zhang Y
Carcinogenesis; 2021 Apr; 42(3):481-492. PubMed ID: 33315089
[TBL] [Abstract][Full Text] [Related]
5. Loss of SIRT4 promotes the self-renewal of Breast Cancer Stem Cells.
Du L; Liu X; Ren Y; Li J; Li P; Jiao Q; Meng P; Wang F; Wang Y; Wang YS; Wang C
Theranostics; 2020; 10(21):9458-9476. PubMed ID: 32863939
[No Abstract] [Full Text] [Related]
6. RhoA is associated with invasion and poor prognosis in colorectal cancer.
Jeong D; Park S; Kim H; Kim CJ; Ahn TS; Bae SB; Kim HJ; Kim TH; Im J; Lee MS; Kwon HY; Baek MJ
Int J Oncol; 2016 Feb; 48(2):714-22. PubMed ID: 26648547
[TBL] [Abstract][Full Text] [Related]
7. SIRT4 Has an Anti-Cancer Role in Cervical Cancer by Inhibiting Glutamine Metabolism
Zhang Y; Niu X; Wang Y; Bao S; Jiang P; Dong X
Anticancer Res; 2024 Jul; 44(7):2861-2870. PubMed ID: 38925807
[TBL] [Abstract][Full Text] [Related]
8. SIRT4 protein suppresses tumor formation in genetic models of Myc-induced B cell lymphoma.
Jeong SM; Lee A; Lee J; Haigis MC
J Biol Chem; 2014 Feb; 289(7):4135-44. PubMed ID: 24368766
[TBL] [Abstract][Full Text] [Related]
9. Sirtuin-4 (SIRT4) is downregulated and associated with some clinicopathological features in gastric adenocarcinoma.
Huang G; Cui F; Yu F; Lu H; Zhang M; Tang H; Peng Z
Biomed Pharmacother; 2015 May; 72():135-9. PubMed ID: 26054687
[TBL] [Abstract][Full Text] [Related]
10. Cellular apoptosis susceptibility (chromosome segregation 1-like, CSE1L) gene is a key regulator of apoptosis, migration and invasion in colorectal cancer.
Alnabulsi A; Agouni A; Mitra S; Garcia-Murillas I; Carpenter B; Bird S; Murray GI
J Pathol; 2012 Dec; 228(4):471-81. PubMed ID: 22450763
[TBL] [Abstract][Full Text] [Related]
11. [Abnormal expression of APRIL in colorectal cancer cells promotes tumor growth and metastasis].
Wang GH; Lu MH; Wang JC; Wang F; Ding WF; Wang YG; Ju SQ; Wang HM
Zhonghua Zhong Liu Za Zhi; 2013 Apr; 35(4):249-55. PubMed ID: 23985251
[TBL] [Abstract][Full Text] [Related]
12. SIRT4 inhibits the proliferation, migration, and invasion abilities of thyroid cancer cells by inhibiting glutamine metabolism.
Chen Z; Lin J; Feng S; Chen X; Huang H; Wang C; Yu Y; He Y; Han S; Zheng L; Huang G
Onco Targets Ther; 2019; 12():2397-2408. PubMed ID: 30992675
[TBL] [Abstract][Full Text] [Related]
13. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
14. SIRT4 inhibits cigarette smoke extracts-induced mononuclear cell adhesion to human pulmonary microvascular endothelial cells via regulating NF-κB activity.
Chen Y; Wang H; Luo G; Dai X
Toxicol Lett; 2014 May; 226(3):320-7. PubMed ID: 24603126
[TBL] [Abstract][Full Text] [Related]
15. N-cadherin, a novel prognostic biomarker, drives malignant progression of colorectal cancer.
Yan X; Yan L; Liu S; Shan Z; Tian Y; Jin Z
Mol Med Rep; 2015 Aug; 12(2):2999-3006. PubMed ID: 25936636
[TBL] [Abstract][Full Text] [Related]
16. DDX3 as a strongest prognosis marker and its downregulation promotes metastasis in colorectal cancer.
Su CY; Lin TC; Lin YF; Chen MH; Lee CH; Wang HY; Lee YC; Liu YP; Chen CL; Hsiao M
Oncotarget; 2015 Jul; 6(21):18602-12. PubMed ID: 26087195
[TBL] [Abstract][Full Text] [Related]
17. Heat shock protein 90 promotes epithelial to mesenchymal transition, invasion, and migration in colorectal cancer.
Nagaraju GP; Long TE; Park W; Landry JC; Taliaferro-Smith L; Farris AB; Diaz R; El-Rayes BF
Mol Carcinog; 2015 Oct; 54(10):1147-58. PubMed ID: 24861206
[TBL] [Abstract][Full Text] [Related]
18. Overexpression of sirt7 exhibits oncogenic property and serves as a prognostic factor in colorectal cancer.
Yu H; Ye W; Wu J; Meng X; Liu RY; Ying X; Zhou Y; Wang H; Pan C; Huang W
Clin Cancer Res; 2014 Jul; 20(13):3434-45. PubMed ID: 24771643
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of SIRT4 inhibits the proliferation of gastric cancer cells through cell cycle arrest.
Hu Y; Lin J; Lin Y; Chen X; Zhu G; Huang G
Oncol Lett; 2019 Feb; 17(2):2171-2176. PubMed ID: 30745932
[TBL] [Abstract][Full Text] [Related]
20. Decreased expression of microRNA-625 is associated with tumor metastasis and poor prognosis in patients with colorectal cancer.
Lou X; Qi X; Zhang Y; Long H; Yang J
J Surg Oncol; 2013 Sep; 108(4):230-5. PubMed ID: 23861214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
